Back
Corcept Therapeutics Stock Price Chart
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
CORT
Corcept Therapeutics
Last Price:
$58.65
Seasonality Move:
2.99%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.81 | Buy |
| 20-day SMA: | 58.19 | Buy |
| 50-day SMA: | 60.65 | Sell |
| 200-day SMA: | 46.86 | Buy |
| 8-day EMA: | 22.99 | Buy |
| 20-day EMA: | 10.55 | Buy |
| 50-day EMA: | 4.47 | Buy |
| 200-day EMA: | 1.15 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.23 | Buy |
| Relative Strength Index (14 RSI): | 48.95 | Sell |
| Chaikin Money Flow: | 1280441 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.66 - 67.46) | Sell |
| Bollinger Bands (100): | (51.04 - 63.8) | Buy |
Corcept Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 58.66 while CORT 8-day simple moving average is 56.81, which is a Buy signal.
-
The stock price of CORT is 58.66 while Corcept Therapeutics 20-day SMA is 58.19, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 60.65 while CORT share price is 58.66, making it a Sell technically.
-
CORT stock price is 58.66 and Corcept Therapeutics 200-day simple moving average is 46.86, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
58
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $58.66. The Score for CORT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
6.2B
Price in USD:
58.66
Share Volume:
1.9M
Corcept Therapeutics 52-Week Range
52-Week High:
75.00
52-Week Low:
20.84
Buy
58
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 58.66 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 58.66 while CORT 8-day exponential moving average is 22.99, which is a Buy signal.
-
The stock price of CORT is 58.66 while Corcept Therapeutics 20-day EMA is 10.55, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 4.47 while CORT share price is 58.66, making it a Buy technically.
-
CORT stock price is 58.66 and Corcept Therapeutics 200-day simple moving average is 1.15, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $1.63 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 8.23, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 48.95, which suggest Corcept Therapeutics is oversold
-
The Bollinger Bands (25) for Corcept Therapeutics is (54.66 - 67.46), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (51.04 - 63.8), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.